In the past 15 years, South Korea has experienced astounding growth in clinical trials due to its mix of clinical experience, infrastructure, population density, demographics, educated workforce, and a supportive government. In the past 5 years, Korea has conducted more industry-sponsored drug studies than any other Asian country, and the capital city of Seoul is now the world’s top-ranked location for trials.  (Life Science Leader)